1
For Immediate Release                                               Exhibit 99.1

                               AMEDISYS QUANTIFIES
                        NET SERVICE REVENUE OVERSTATEMENT

  MANAGEMENT EXPECTS PROFITABLE SECOND QUARTER AND IMPROVED EARNINGS IN SECOND
                                  HALF OF YEAR

BATON ROUGE, Louisiana (July 17, 2001) - Amedisys, Inc. (OTC BB: "AMED") today
detailed the impact of a previously announced overstatement in net service
revenue for the quarters ended December 31, 2000 and March 31, 2001.

The implementation of the Medicare Prospective Payment System ("PPS") on October
1, 2000 made significant changes to the reimbursement methodology for home
health nursing companies, necessitating changes to systems which process
provider and patient-specific claims for both the Medicare intermediary and the
individual home health provider. The Company noted certain discrepancies in
these systems which had the effect of overstating net service revenues in the
fourth quarter of 2000 and the first quarter of 2001. The Company disclosed
these discrepancies to the investment community in a news release dated June 13,
2001 and a conference call held on June 14, 2001.

The Company, with the assistance of the Company's external auditing firm, has
completed a review of all Medicare patients served and has quantified the impact
of the net service revenue overstatement upon its previously reported operating
results. The decrease in revenue for the six months ended March 31, 2001 totaled
approximately $6.6 million and will be partially offset by a reversal of
$900,000 in incentive compensation, resulting in a net negative adjustment to
operating income of $5.7 million. Of this $5.7 million, $2.6 million is
attributable to the fourth quarter of 2000 and $3.1 million is attributable to
the first quarter of 2001.

After taking the restatement into account, Amedisys will report an operating
loss before income taxes and special items of ($130,000) on revenues of
approximately $19.4 million for the quarter ended December 31, 2000. For the
quarter ended March 31, 2001, the Company will report an operating loss before
income taxes and special items of ($409,000) on revenues of approximately $22.2
million. For the twelve months ended December 31, 2000, the Company will report
an operating loss before income taxes and special items of ($4.3) million on
revenues of approximately $88.2 million.

"The problems with our systems that resulted in the revenue overstatement have
been identified and corrected, and we are confident that such problems will not
recur in the future," stated William F. Borne, Chairman and Chief Executive
Officer of Amedisys, Inc. "Our business is sound, patient admissions are
growing, recent acquisitions have been assimilated into the Amedisys
organization successfully, and we expect to participate fully in the growth of
the home nursing industry in coming years. We will continue to pursue both
internal and external growth opportunities within our industry, and we consider
the Company well-positioned to accomplish these goals."

   2

"As noted in an earlier news release, management expects the Company to be
profitable in the quarter ended June 30, 2001, and we anticipate growth in
revenue and earnings during the second half of the year," concluded Borne.

The Company expects to file an amended 10-K for the year ended December 31,
2000, and an amended 10-Q for the quarter ended March 31, 2001 in the near
future.

A conference call has been scheduled for 8:30 a.m. Eastern Time on Wednesday,
July 18, 2001, to further discuss the issues which underlie this net service
revenue overstatement. The call will be hosted by Bill Borne, Chief Executive
Officer of Amedisys, Inc.

TO PARTICIPATE IN THE CONFERENCE CALL, PLEASE DIAL 800-388-8975 A FEW MINUTES
BEFORE 8:30 A.M. EDT ON JULY 18, 2001. A REPLAY OF THE CONFERENCE CALL WILL BE
AVAILABLE THROUGH JULY 25, 2001, BY DIALING 800-428-6051. THE ACCESS CODE IS
#202030 FOR THE REPLAY.

Amedisys, Inc. is a multi-regional provider of home health nursing services and
is headquartered in Baton Rouge, Louisiana. Its common stock trades on the OTC
Bulletin Board under the symbol "AMED".

This press release includes statements that may constitute "forward-looking"
statements, usually containing the words "believe", "estimate", "project",
"expect" or similar expressions. Forward-looking statements inherently involve
risks and uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or contribute to
such differences include, but are not limited to, continued acceptance of the
Company's products and services in the marketplace, competitive factors, changes
in government reimbursement procedures, dependence upon third-party vendors, and
other risks discussed in the Company's periodic filings with the Securities and
Exchange Commission. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this release.

    Additional information on this Company can be found on the World Wide Web

                             http://www.amedisys.com

                    For further information, please contact:

             John Joffrion, Senior Vice President at (225) 292-2031
                                       or
   RJ Falkner & Company, Inc., Investor Relations Counsel at (800) 377-9893 or
                                   via e-mail

                              at info@rjfalkner.com